← All stocks

Immuneering Corp

IMRX No buying or selling
CIK 0001790340 #3449 in the set updated 19 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

9 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Zeskind Benjamin J.
PRESIDENT AND CEO
2,315,252
$10.56M
+1.5%
Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
382,531
$1.74M
+10.6%
Feinberg Peter
Director
292,207
$1.33M
+28.6%
Schall Thomas J.
Director
74,530
$339.98K
+2,470%
Neufeld Leah R
CHIEF PEOPLE OFFICER
29,598
$135.02K
+195.1%
Morales Mallory
SVP Finance, CAO
27,533
$125.60K
+116.2%
Brakewood Harold Eugene
Chief Business Officer
11,050
$50.41K
+183.3%
HAUSMAN DIANA
Director
5,500
$25.09K
Bookman Michael
CHIEF LEGAL OFFICER, SECRETARY
4,870
$22.22K
+26.5%

No percentages here. This company's share count has moved by a factor of 2.2 over the window, from 29,841,883 to 64,697,219 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 30 Jul 2021